Interactive database of aBLA activity, USPTO post grant proceedings and patent litigations for CDER-listed / 505(b)(2) biologic drugs and cellular and gene therapies, including company news, regulatory updates and statistical analysis
March 08, 2022
October 15, 2020
April 21, 2020
January 22 - 24, 2020 Informa’s Specialty Therapies and Biosimilars Congress
September 17, 2019 Washington, DC - A Complimentary Venable LLP Seminar/Webcast
October 27, 2021
February 16, 2021
June 15, 2020